Invitrogen™ DCP Microdevelopments™ BacMam LRRK2 G2019S Reagent

Description

• BacMam LRRK2 G2019S Reagent Lets You: • Easily overexpress full-length LRRK2 G2019S in most cellular backgrounds • Understand the effects of therapeutically relevant LRRK2 mutations • Conduct the LRRK2 cellular assays you need Examine LRRK2 Mutations with BacMam Reagents Using the BacMam LRRK2 therapeutic mutant reagents G2019S and D1994A (Cat
• no
• A13390) along with the wild-type LRRK2 reagent (Cat
• no
• A13388) enables you to research and determine LRRK2 mutant mechanisms
• You can also evaluate the difference in the cellular response to a stimulus among the different mutations
• Expand Your Battery of Cellular Assays for LRRK2 Once full length LRRK2 G2019S has been introduced into your cellular background, the transduced cells allow you the flexibility to conduct many types of LRRK2 experiments, including studies of regulation of physiologically functional pathways (including signaling pathways leading to function), and identification of potential physiological substrates for LRRK2
• Overexpress Full-Length LRRK2 in Most Mammalian Cell Backgrounds BacMam technology utilizes a modified baculovirus to deliver and express genes in mammalian cells with minimal effort and toxicity
• It enables efficient, titratable LRRK2 G2019S protein expression in various mammalian cellular backgrounds, including cell lines that may not be compatible with traditional transfection methods such as primary neurons and neuroblastoma cell lines
• For research use only
• Not intended for any human or animal therapeutic or diagnostic use.